drugset / Trial / NCT00726570

Alterations of Blood Clotting With the Use of Sequential Compression Devices on the Lower Limbs

NCT00726570

Terminated 40 enrolled University of Parma
RandomizedParallel-groupOpen-labelDiagnostic

Summary

This study aims to assess possible alteration in coagulation (blood clotting) following treatment with sequential compression devices (SCD) plus low-molecular weight heparin (LMWH) as opposed to LMWH alone. The investigators will examine coagulation in the early postoperative period of patients undergoing major abdominal surgery during their stay in our Intensive Care Unit. In addition to common laboratory tests, the investigators will examine coagulation using TEG®, a device which allows a semi-quantitative examination of all phases of coagulation.

Timeline

Start
2008-08
Primary completion
2010-11
Completion
2010-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Dalteparin sodium Other / unclassified 2500 iu
Background Dalteparin sodium Other / unclassified 5000 iu